October 510(k) clearances came a median 125 days after filing, quicker than September
Traditional 510(k)s took a median 140.5 days and special 510(k)s 30, according to openFDA data. About a third of October's 293 clearances came more than 180 days after FDA received the filing.

A device cleared through the Food and Drug Administration's 510(k) pathway in October typically got its decision about four months after FDA received the filing. The median was 125 days across the month's 293 clearances, according to an analysis of openFDA data.
That was quicker than September's median of 140.5 days across 318 clearances, and slower than the 116-day median for the 303 clearances issued in October 2025.
Why it matters: For a device maker, the stretch between filing and clearance is time before the product can be sold in the U.S. The type of filing makes a large difference: special 510(k)s cleared in a median 30 days in October, while traditional 510(k)s took 140.5.
By submission type
The 238 traditional 510(k)s cleared in October took a median 140.5 days, compared with 147.5 days in September and 134 days in October 2025. The 50 special 510(k)s took a median 30 days, against 36.5 in September and 29 a year earlier.
Across all October clearances, the middle half took between 78 and 224 days. Ninety-nine came within 90 days of receipt, and another 99, about 34% of the total, came more than 180 days after. That over-180-day share compared with 39% in September and 28% in October 2025.
Several October clearances show the range. The twiist insulin dosing algorithm's type 2 diabetes expansion was cleared 80 days after FDA received it, Neocis's Yomi S pterygoid implant expansion took 174 days and CMR Surgical's Versius Plus gynecology clearance took 188. PulseAI's smartwatch ECG analysis software took 302 days. All four were traditional 510(k)s.
Five October clearances came more than a year after filing. The longest were a TECAR therapy device from China's Shenzhen Dongdixin Technology, received July 23, 2025, and cleared Oct. 13, 2026, after 447 days, and BD Vacutainer blood collection tubes from Becton, Dickinson and Co., received July 28, 2025, and cleared Oct. 16, 2026, after 445 days.
At the fast end among special 510(k)s, Beta Bionics' Mint ACE Pump was cleared Oct. 21, 26 days after FDA received it on Sept. 25.
Elapsed time here is calendar days between the date FDA received a submission and the date it decided. It does not separate FDA's own review time from periods when a submission was waiting on the applicant, so it is not a direct measure of the agency's speed.
Method
The analysis counts openFDA device 510(k) records with a decision date in the stated month and a decision code of SESE, meaning substantially equivalent; De Novo grants are excluded. Elapsed time is the number of calendar days between the date_received and decision_date fields. Two October records list a receipt date one day before the decision; they are included, and medians were used to limit the influence of outliers.
The latest decision date in the October data is Oct. 30. Records added in later openFDA updates could shift the medians, and November's figures will show whether October's faster pace holds.



